Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001451612-26-000020 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 30, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
31,283
Total Value
$3,424,800.35
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 29, 2026 | Sale | 10,658 | $108.28 | $1,154,048.24 | 2,402,089 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 7,833 | $109.75 | $859,671.75 | 2,394,256 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 7,602 | $110.67 | $841,313.34 | 2,386,654 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 907 | $111.20 | $100,858.40 | 2,385,747 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 1,688 | $108.28 | $182,776.64 | 464,389 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 1,239 | $109.75 | $135,980.25 | 463,150 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 1,199 | $110.67 | $132,693.33 | 461,951 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 29, 2026 | Sale | 157 | $111.20 | $17,458.40 | 461,794 | Indirect | See footnote | View Details |